AQUILO CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q1 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ACET | 2.46M | $1.85M |
 | RPTX | 1.29M | $1.28M |
 | DTIL | 726K | $3.46M |
 | ARWR | 550K | $7.01M |
 | ARVN | 361K | $2.53M |
 | IMTX | 305K | $1.38M |
 | RGNX | 271K | $1.94M |
 | BCYC | 172K | $1.46M |
 | KYMR | 139K | $3.79M |
 | ZYME | 84K | $1.01M |
 | PTGX | 82K | $3.95M |
Adicet Bio, Inc.
ACET
Shares Held
2.46M
Value
$1.85M
Repare Therapeutics Inc.
RPTX
Shares Held
1.29M
Value
$1.28M
Precision BioSciences, Inc.
DTIL
Shares Held
726K
Value
$3.46M
Arrowhead Pharmaceuticals, Inc.
ARWR
Shares Held
550K
Value
$7.01M
Arvinas, Inc.
ARVN
Shares Held
361K
Value
$2.53M
Immatics N.V.
IMTX
Shares Held
305K
Value
$1.38M
REGENXBIO Inc.
RGNX
Shares Held
271K
Value
$1.94M
Bicycle Therapeutics plc
BCYC
Shares Held
172K
Value
$1.46M
Kymera Therapeutics, Inc.
KYMR
Shares Held
139K
Value
$3.79M
Zymeworks Inc.
ZYME
Shares Held
84K
Value
$1.01M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
82K
Value
$3.95M